Your browser doesn't support javascript.
loading
The effect of rs5758550 on CYP2D6*2 phenotype and formation of endoxifen in breast cancer patients using tamoxifen.
Sanchez-Spitman, Anabel B; Moes, Dirk-Jan Ar; Gelderblom, Hans; Dezentjé, Vincent O; Swen, Jesse J; Guchelaar, Henk-Jan.
Afiliação
  • Sanchez-Spitman AB; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Moes DA; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Dezentjé VO; Department of Medical Oncology, Reinier de Graaf, Delft, The Netherlands.
  • Swen JJ; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Guchelaar HJ; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Pharmacogenomics ; 18(12): 1125-1132, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28745555

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais / Citocromo P-450 CYP2D6 Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais / Citocromo P-450 CYP2D6 Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article